Loading clinical trials...
Loading clinical trials...
An Open-label, Multi-centre, Multi-national Post-marketing Non-interventional Observational Study of the Use of Zonisamide (ZNS) in the Adjunctive Treatment of Adult Patients With Partial Onset Seizures Treated With One Antiepileptic Drug (AED) as Baseline Medication
Conditions
Interventions
Zonisamide tablets
Locations
37
Austria
Ried, Austria
Hillerød, Denmark
Asperg, Germany
Baesweiler, Germany
Berlin, Germany
Bielefeld, Germany
Start Date
March 1, 2012
Primary Completion Date
June 1, 2013
Completion Date
August 1, 2013
Last Updated
June 18, 2023
NCT06960811
NCT03288129
NCT02072824
NCT00655486
NCT01710657
NCT00866775
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions